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Level 1 STEMI PTs w/angiogram, N=2062
Death w/CTO N¼297 w/o CTO N¼1765 p-value
In-Hospital Death, N (%) 39 (13.1) 63 (3.6) <0.0001
Death in 30 days, N (%) 45 (15.2) 75 (4.3) <0.0001
Death in 1 year, N (%) 65 (21.9) 133 (7.5) <0.0001
Level 2 NSTEACS PTs w/angiogram, N=827
Death w/CTO N¼203 w/o CTO N¼624 p-value
In-Hospital Death, N (%) 11 (5.4) 10 (1.6) 0.0027
Death in 30 days, N (%) 14 (6.9) 13 (2.1) 0.0008
Death in 1 year, N (%)* 11 (9.5) 25 (6.4) 0.2647
*N¼504 for 1 year (excluding 2012)
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hospital, 30 day, and one year mortalities than STEMI PTs without a CTO. PTs with
NSTEACS and a CTO have higher in-hospital and 30 day mortality than NSTEACS
PTs without a CTO, and there is a non-signiﬁcant trend towards increased one year
mortality for PTs with a CTO. Strategies to reduce this increased mortality are needed.
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Impact of Chronic Total Occlusions on Mortality in Patients Presenting With
Cardiac Arrest
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Background: Cardiac arrest (CA) is often the result of both acute and chronic
coronary artery disease (CAD) particularly when it is caused by ventricular tachy-
cardia or ﬁbrillation (VT/VF). Therapeutic hypothermia has been shown to decrease
mortality and after resuscitated CA (rCA). It has been demonstrated that a chronic
total occlusion (CTO) in the non-infarct artery in patients (Pts) with ST segment
elevation myocardial infarction (STEMI) is associated with increased mortality.
The incidence and effect of CTOs in Pts with rCA has not been well described.
Further the incidence and effect of CTOs in rCA Pts as the result of STEMI is
unknown.
Methods: The Minneapolis Heart Institute has developed formalized protocols for both
STEMI (Level One, L1) and cardiac arrest and sequential therapeutic hypothermia (Cool-
It). From 2006-May 2012, 164 sequential Pts who had been enrolled in the Cool-It
program who presented with VT/VF and underwent angiography were evaluated for the
presence of at least one CTO in a major coronary vessel. From 2006-May 2012, 121 PTs
who had been enrolled in the Cool-It program and underwent angiography but also
suffered from STEMI were also evaluated for CTOs. In-hospital, 30 day, and 1 year
mortality were compared between Pts who did and did not have CTO. STEMI Pts who
presented with rCAwere compared to STEMI Pts without rCA for the presence of a CTO.
Results: See table below:Cool-It Pts w/angiogram and VT/VF, N=164
Death w/CTO N¼37 w/o CTO N¼127 p-value
In-Hospital Death, N (%) 15 (40.5) 37 (29.1) 0.1895
Death in 30 days, N (%) 16 (43.2) 40 (31.5) 0.1848
Death in 1 year, N (%) 17 (46.0) 43 (33.9) 0.1792
Cool-It Pts w/angiogram and STEMI, N¼121
Death w/CTO N¼30 w/o CTO N¼91 p-value
In-Hospital Death, N (%) 16 (53.3) 33 (36.3) 0.0986
Death in 30 days, N (%) 15 (50) 35 (38.5) 0.2657
Death in 1 year, N (%) 17 (56.7) 37 (40.7) 0.1261
STEMI Pts from 2007-2011, N=2062
w/rCA w/o rCA p-value
w/CTO, N (% for column) 22 (24.7) 275 (13.9) 0.0046
w/o CTO, N (% for column) 67 (75.3) 1698 (86.1)Conclusions: These data demonstrate that rCA Pts presenting with VT/VF and who
have a CTO appear to have similar mortality compared to those without a CTO. Pts
with and without a CTO who presented with rCA and STEMI have similar mortality
although there is a trend in favor of those without a CTO. STEMI Pts with rCA have
a higher incidence of a CTO than do STEMI Pts without rCA. Further efforts to
understand, treat, and avoid CA in Pts with a CTO are warranted.JACC Vol 62/18S1/Suppl B j October 27–November 1, 2013 j TCT AbTCT-372
“Full metal jacket” (stented length > or [ 50 mm) using drug-eluting stents for
chronic total occlusive lesions.
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Background: Limiteddata exists onpatientswhohaveundergonedrug eluting stent (DES)
implantation of long chronic total occlusive (CTO) lesion in native coronary arteries.
Methods:Wedeﬁned longcontinuousstent implantation (stent length> or¼ 50mm)as"full
metal jacket" (FMJ). FromApril 2007 toMarch 2013, 344 consecutive patients (361 lesions)
who underwent FMJ using any DESs for de novo lesion were enrolled. Subjects were clas-
siﬁed into twogroups: thepatientswithCTOlesion (CTOgroup,113patients, 114 lesions) and
without CTO lesion (non-CTO group, 239 patients, 247 lesions). The two groups were
compared for mean 2419 months clinical outcomes. Endpoints were freedom from target
lesion revascularization (TLR) and major adverse cardiovascular events (MACE) deﬁned as
composite of TLR, myocardial infarction and all cause death at 5 years after percutaneous
coronary interventionprocedure.Thiswas a single center non-randomized retrospective study.
Results: CTOgroupwas younger than non-CTOgroup (66.00.9 vs. 70.00.6, p<0.05).
The percentage of male gender and hyperlipidemia were higher in CTO group than non-
CTO group (84.2% vs. 69.6%, p<0.05 and 58.8% vs. 47.0%, p<0.05, respectively). There
were no signiﬁcant differences between both study arms in percentages of diabetes mellitus
(43.0% vs. 48.6%, p¼0.32), hypertension (71.9% vs. 75.2%, p¼0.51), hemodialysis (2.6%
vs. 5.3%, p¼0.26) and current smoker (19.3% vs. 17.1%). Target vessel wasmore often the
right coronary artery in CTO group than non-CTO group (71.1% vs. 33.2%, p<0.05). The
mean total length of implanted stents was longer in CTO group than non-CTO group
(72.81.4mmvs. 60.90.9mm,p<0.05). Intravascular ultrasoundwas used in 70.0% and
follow up rate of angiographywas 75.9%. Regarding the long-term clinical outcomes, there
were no signiﬁcant differences in the rate of freedom from TLR (60.510.5% vs.
76.94.7%, Log rank p¼0.48) andMACE (53.89.9%vs. 67.24.8%,Log rank p¼0.88)
at 5 years estimated using the Kaplan-Meier methods compared to non-CTO group.
Conclusions: The strategy of FMJ using DES was acceptable for CTO lesions.
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Decreasing R-wave Amplitude During Percutaneous Coronary Intervention for
Chronic Total Occlusion in the Retrograde Approach
Tatsuya Nakachi1, Hidekuni Kirigaya1, Daiki Gyoutoku1, Kazuki Fukui1
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Background: The use of retrograde approach for recanalization of chronic total occlusion
(CTO) has been established with improved success rates. During the procedure of percuta-
neous coronary intervention (PCI) for CTO lesions in the retrograde approach, electrocar-
diographic R-wave amplitudes often decrease in many leads. Because the differential
diagnoses of low voltages on electrocardiogram (ECG) include pericardial effusion, the
presence of these changes should increase the index of suspicion for a signiﬁcant pericardial
effusiondue to coronaryperforation andprompt further evaluation suchas echocardiography.
Methods: We analyzed the recent 30 patients (group-R, age 6512) who underwent
successful PCI for CTO lesions in the retrograde approach and the recent 30
patients (group-E, age 6010) who underwent treatment for pericardial effusion
during catheter intervention. Group-E was divided into 2 groups according to whether
requiring drainage of effusion [group-E/D(+) ,n¼15] or not [group E/D(-), n¼15].
Pre-ECG was deﬁned as the ECG just before the catheter intervention. Post-ECG was
deﬁned as the ECG just before the procedure of drainage for Group-E/D(+) and the
ECG immediately after catheter intervention for other groups.
Results: In comparison of pre-ECG and post-ECG, the leads in which R-wave
amplitude signiﬁcantly decreased were I, II, aVL, V1,V4, V5, and V6 in group-R; I,
II, aVL,V4, V5, and V6 in group-E/D(+); but only aVL in group-E/D(-). Heart rate
(HR) signiﬁcantly increased in group-E /D(+) (6412 to 8318, p¼0.0034) between
the 2 ECGs, but not in group-R and group-E/D(-). Comparing group-R and group-E/
D(+), the rate of R-wave amplitude between the 2 ECGs [(R-wave amplitude in post-
ECG)/(R-wave amplitude in pre-ECG)] was similar in all leads. But the rate of HR
between the 2 ECGs [(HR in post-ECG) / (HR in pre-ECG)] was higher in group-E/
D(+) (0.960.34 vs 1.320.29, p¼0.0024). Comparing group-R and group-E/D(-),
the rate of HR between the 2 ECGs was similar. But the rate of R-wave amplitudes
between the 2 ECGs of group-R was signiﬁcantly lower in leads I(0.660.25 vs
0.990.58, p¼0.0074), II(0.880.33 vs 1.200.41, p¼0.014), V1(0.720.29 vs
1.110.55, p¼0.0019), and V5(0.670.31 vs 0.950.30, p¼0.0042).
Conclusions: During the procedure of PCI for CTO lesions in the retrograde approach,
ECG shows decreasing R-wave amplitudes similarly with the case of pericardial effusion
requiring drainage during catheter intervention. However, by taking HR into account,
decreasingR-wave amplitude during PCI for CTO lesions in the retrograde approach could
bediscriminated fromECGchangesdue topericardial effusionduring catheter intervention.
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Results of the ALSTER CTO-OCT registry: Delayed DES endothelialization
after subintimal recanalization of chronic of total occlusion: Observation by
optical coherence tomography
Christian Heeger1, Martin W. Bergmann1, Karl-Heinz Kuck1
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Table 1. MPI values before and after recanalization of RCA CTO
Basal Early Late P1 P2 P3
2d MPI 0.610.09 0.600.08 0.530.07 0.84 <0.001 <0.001
TD septal MPI 0.580.09 0.570.07 0.530.08 0.33 0.003 <0.001
TD lateral MPI 0.590.08 0.580.08 0.510.07 0.42 <0.001 <0.001
P1: basal vs. earlyMPI, P2: basalvs. lateMPI, P3: early vs. lateMPI, valuesaremeanstd. deviation
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exercise capacity and reduction of mortality. Up to date no adequate information on
stent strut endothelialisation after CTO treatment is available. In particular, the
duration of dual antiplatelet therapy (DAPT) remains an issue of debate. Following
CTO treatment, patients are at risk for restenosis as well as stent thrombosis. DAPT is
able to sufﬁcient reduce frequency of stent thrombosis, but keeps an increased risk of
major bleeding in case of unnecessarily prolonged ingestion. Intracoronary optical
coherence tomography (OCT) is a novel invasive method, which is able to precisely
analyse stent strut endothelialisation. We tested the hypothesis, that OCT detects
delayed endothelialisation after CTO treatment compared to non-CTO PCI.
Methods: We performed diagnostic OCT measurements following successful CTO
treatment (n ¼ 22) as well as non-CTO DES PCI of complex lesions (n ¼ 29). All
Patients had been treated with 2nd generation DES. Mean time point of OCT analysis
was 7.8 months and 6.5 months, respectively (p ¼ 0.83).
Results: The two groups were well matched and similar concerning characteristics.
Stent struts (in total n ¼ 13629) were analysed and classiﬁed by OCT according to
previously described methods (CTO recanalization vs. non-CTO DES; mean +/- SEM):
covered struts: 81.65 +/- 2.9% vs. 97.34 +/- 0.78%, p<0.0001; protruding/uncovered
struts: 10.1 +/- 1.7% vs. 1.4 +/- 0.4%, p<0.0001; malapposed/uncovered struts: 7.9 +/-
2.0 % vs. 1.3 +/- 0.5 %, p<0.001. We performed subgroup analysis concerning CTO
recanalization by antegrade vs. retrograde approach as well as subintimal tracking vs.
non-subintimal tracking methods. No signiﬁcant differences were found concerning
subgroup analysis. No MACE events were detected in this series.
Conclusions: Here we describe delayed stent endothelialisation after CTO treatment.
Our results suggest an urgent need to extend the DAPT after CTO treatment to reduce
the risk of late stent thrombosis. OCT allows interventional cardiologists to safe and
precisely perform follow-up examinations in patients after CTO recanalization with
the ability of individualise the duration of DAPT.
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Eluting Stents in the Treatment of Chronic Total Occlusions: Insights From
a Large Registry of 1,343 Consecutive Patients
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Marie-Claude Morice1, Philippe Garot4
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Background: Second-generation drug-eluting stents (DES) have reduced the occurrence
of target vessel revascularisation (TVR) and stent thrombosis compared to ﬁrst-generation
DES but the clinical impact in chronic total occlusion (CTO) is poorly described.We aimed
to compare long-term outcome after 1st and 2nd-generation DES in patients with CTO.
Methods: Of 1,343 consecutive Patients who underwent PCI for CTO between 2004 and
2012, long termoutcomewas evaluated after successful DES implantation.Major adverse
cardiac events (MACE) including cardiac death, target vessel revascularisation (TVR) and
myocardial infarction (MI) were compared between patients treated with 1st (sirolimus
and paclitaxel) and 2nd -generation DES (everolimus, zotarolimus and biolimus).
Results: Procedural success was achieved in 1000 (74.4 %) patients of which 943
(70.2%) received at least one stent. DES were implanted in 873 patients (65%) who
deﬁned the study population.Patients treated with 1st generation DES (583 patients,
66.9% of the whole population) had a higher rate of current smoking (28% vs. 20%
p¼0.007), were more frequently treated for left anterior descending CTO (37% vs.
29% p¼0.018) and had shorter stent length (46  25 vs. 51  25 mm, p¼) compared
to patients treated by 2nd generation DES. Age, gender, diabetes, and LVEF were
similar between groups. Median follow-up was at 4.1 years (IQR: 2.4-6.5 years).
Patients treated 2nd generation DES had lower MACE rate compared to 1st-genera-
tion DES (12.7% vs. 21.3%, respectively, p¼0.003). The decrease in MACE rate was
driven by lower TVR (8.7%, vs. 13.4%, respectively p¼0.04) whereas cardiac death
and MI were similar between groups (p¼0.32 and p¼0.15, respectively). Cumulative
event rates by Kaplan-Meier analysis showed lower incidence of TVR among patients
treated by 2nd generation stent (p Log Rank ¼0.02).
Conclusions: In patients successfully treated by PCI for CTO, 2nd generation DES
are associated with better long-term clinical outcome, when compared to 1st gener-
ation DES. This is mainly driven by lower TVR rates
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Is Cardiac Tamponade Associated With Adverse Outcome in Patients Treated by
PCI for Chronic Total Coronary Occlusion. An Insight From a Large French
Registry Including More than 1,500 Patients.
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Background: PCI of chronic total occlusion (CTO) has becomemore andmore aggressive
during the last decade, especially because of frequent use of hydrophilic, hard and stiffwires,
which have increased the rate of success. Indeed, the incidence and clinical consequences of
cardiac tamponade in contemporary practice remain relatively unknown.B118 JACC Vol 62/18S1/Suppl B j October 27–NMethods: Between October 2003 and June 2010, a total of 1509 consecutive patients
were treated by PCI for a CTO deﬁned as the presence of TIMI 0 ﬂowwithin an occluded
arterial segment of greater than 3 months standing. The population characteristics were
compared regarding the presence of per and post-procedural tamponade.
Results: A cardiac tamponade occurred in 18/1509 patients (1.2%). As opposed to
patients with a tamponade-free procedure, patients who have experienced cardiac
tamponade were older (68.610.34 vs. 63.411.29, p¼0.03) and had similar risk
factors (diabetes in 27% and dyslipidemia in 64%). Cardiac tamponade occurred more
frequently in experienced operators reﬂecting more complex procedures. Absence of
visible stump was associated with higher rate of cardiac tamponade (50% vs. 24.8% for
patients without tamponade, p¼0.02). There were no differences regarding other
angiographic characteristics between the two groups (calciﬁcations, proximal tortuosi-
ties, lesion length). The use of a tornus device and a retrograde approach were associated
with higher rates of cardiac tamponade (0.17vs 0.02 p¼0.01, and 0.28vs 0.01 p¼0.02,
respectively). Procedural duration was longer in patients in whom a cardiac tamponade
occurred (12424 minutes, vs. 9237 minutes, p¼0.01) and success rate was equal
(0.77 vs 0.70., p¼0.61, respectively). Importantly, in-hospital stay was longer (7.23.6,
vs. 3.13, p<0.0001, respectively), and rate of in-hospital death was higher among
patients who have experienced cardiac tamponade compared to those without per and
post-procedural tamponade (11% vs. 1%, p¼0.01, respectively).
Conclusions: Cardiac tamponade occurred in 1.2% of a broad population of consecutive
patients treated by PCI for chronic total coronary occlusion. Absence of visible stump and
use of aggressive devices and strategies were more frequently associate.
TCT-377
Myocardial Performance Index After Successful Recanalization of Chronic Total
Coronary Occlusions
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Background: Percutaneous recanalization of chronic total coronary occlusions (CTO)
tends to show a positive effect on LV remodeling and ejection fraction (EF). Never-
theless, its effects on global cardiac functions are yet to be fully understood. Myocardial
performance index (MPI) is likely to be more effective for analysis of global cardiac
dysfunction than systolic and diastolic measures alone. The aim of this study was to
evaluate the effects of recanalization of CTO on global cardiac functions by using MPI.
Methods: We evaluated 25 patients (20 men, mean age 57.514.1 years) who had
ischemia on myocardial perfusion imaging and underwent successful percutaneous
coronary intervention of right coronary artery (RCA) CTO. All patients underwent
transthoracic echocardiography before (basal), 24 hours after (early) and at third
months (late) of successful PCI. The MPI was calculated by using pulse wave tissue
Doppler (TD) echocardiography.
Results: There was no difference between basal, early and late left ventricular ejection
fraction values (53.510.2, 53.39.5, 53.311.2, respectively). The MPI at third
month was signiﬁcantly increased compared to the basal and early MPI (0.610.09 vs.
0.530.07; p <0.001 and 0.600.08 vs. 0.530.07; p<0.001, respectively). On the
other hand, there was no signiﬁcant difference between basal and early MPI (0.610.09
vs. 0.600.08; p¼0.84, respectively). Also, TDMPI within 3 months was signiﬁcantly
increased when compared to others (0.580.9 vs. 0.530.8; p¼0.003, 0.570.07 vs.
0.530.8; p<0.001, respectively for TD MPI septal and 0.590.08 vs. 0.510.07;
p<0.001, 0.580.08 vs. 0.510.07; p<0.001, respectively for TD MPI lateral).Conclusions: In this study, we have shown that successful recanalization of CTO
results in increased MPI-indicated global cardiac functions within 3 months, while the
EF values remain unchanged.
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Background: New generation drug eluting stents (DES) signiﬁcantly improved short-
and long-term vessel patency after CTO recanalization. Data on the performance ofovember 1, 2013 j TCT Abstracts/POSTER/Chronic Total Occlusions
